Last reviewed · How we verify
Subconjunctival dexamethasone — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Subconjunctival dexamethasone (Subconjunctival dexamethasone) — Sun Yat-sen University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Subconjunctival dexamethasone TARGET | Subconjunctival dexamethasone | Sun Yat-sen University | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Subconjunctival dexamethasone CI watch — RSS
- Subconjunctival dexamethasone CI watch — Atom
- Subconjunctival dexamethasone CI watch — JSON
- Subconjunctival dexamethasone alone — RSS
Cite this brief
Drug Landscape (2026). Subconjunctival dexamethasone — Competitive Intelligence Brief. https://druglandscape.com/ci/subconjunctival-dexamethasone. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing